What is the recommended dose of furosemide (Lasix) for patients with cirrhosis and ascites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Furosemide for Cirrhosis with Ascites

The recommended initial dose of furosemide for patients with cirrhosis and ascites is 40 mg/day orally, typically given in combination with spironolactone 100 mg/day, with doses that can be increased simultaneously every 3-5 days (maintaining a 100:40 mg ratio) up to a maximum of 160 mg/day of furosemide and 400 mg/day of spironolactone. 1

Initial Dosing Strategy

  • The standard diuretic regimen for cirrhotic ascites consists of single morning doses of oral spironolactone and furosemide, beginning with 100 mg of spironolactone and 40 mg of furosemide 1
  • Oral administration is preferred over intravenous furosemide due to good oral bioavailability in cirrhotic patients and the risk of acute reductions in glomerular filtration rate with IV administration 1
  • Single morning dosing is recommended to maximize patient compliance 1

Dose Titration

  • Both diuretics can be increased simultaneously every 3-5 days (maintaining the 100 mg:40 mg ratio) if weight loss and natriuresis are inadequate 1
  • This ratio generally maintains normokalemia while achieving effective diuresis 1
  • Maximum recommended doses are 400 mg/day of spironolactone and 160 mg/day of furosemide 1
  • For patients without edema, weight loss should be limited to 0.5 kg/day; for those with edema, there is no strict limit but careful monitoring is required 1

Special Considerations

  • Furosemide can be temporarily withheld in patients presenting with hypokalemia, which is common in alcoholic hepatitis 1
  • Patients with parenchymal renal disease may tolerate less spironolactone due to risk of hyperkalemia 1
  • In cases of tender gynecomastia, amiloride (10-40 mg/day) can be substituted for spironolactone 1
  • Diuretics should be discontinued if severe hyponatremia (serum sodium <120-125 mmol/L), acute kidney injury, worsening hepatic encephalopathy, or incapacitating muscle cramps develop 1

Alternative Approaches

  • For the first episode of ascites, some evidence suggests starting with spironolactone monotherapy and adding furosemide only if needed, particularly in outpatient settings 1
  • However, most patients eventually require combination therapy, and starting with both drugs appears to be the preferred approach for achieving rapid natriuresis while maintaining normal potassium levels 1
  • For patients with tense ascites, large-volume paracentesis followed by diuretic therapy is appropriate 1

Monitoring

  • Regular monitoring of body weight, vital signs, serum creatinine, sodium, and potassium is essential during diuretic therapy 1
  • If serum sodium decreases below 125 mmol/L, diuretics should be reduced or discontinued 1
  • Loop diuretics should be reduced or stopped in case of hypokalemia (<3 mmol/L), while aldosterone antagonists should be reduced or stopped in case of hyperkalemia (>6 mmol/L) 1

Refractory Ascites

  • Refractory ascites is defined as fluid overload that fails to respond to sodium restriction and maximum diuretic doses (spironolactone 400 mg/day and furosemide 160 mg/day) 1, 2
  • For these patients, large-volume paracentesis, transjugular intrahepatic portosystemic shunt (TIPS), or liver transplantation may be considered 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of cirrhotic ascites.

Acta gastro-enterologica Belgica, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.